Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Atorvastatin + ascorbic acid is a combination of two active ingredients: atorvastatin, a statin (HMG-CoA reductase inhibitor) used to lower cholesterol and reduce cardiovascular risk, and ascorbic acid (vitamin C), an essential nutrient with antioxidant properties. This combination has been studied for its potential synergistic effects in specific clinical settings. For example, research indicates that the combined use of oral atorvastatin and vitamin C may be more effective than atorvastatin alone in reducing the incidence of postoperative atrial fibrillation after coronary artery bypass graft surgery[2]. Additionally, cocrystal formulations of these two agents have been explored to improve dissolution rates and safety profiles in preclinical models[3]. Atorvastatin works by inhibiting HMG-CoA reductase, thereby lowering LDL cholesterol and triglycerides while increasing HDL cholesterol[5][7]. Ascorbic acid acts primarily as an antioxidant and supports various enzymatic reactions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on atorvastatin + ascorbic acid.